title: Reversal of delayed hyperacute renal allograft rejection with a tacrolimus-based therapeutic regimen.
authors.affiliation: Department of Surgery, University of Chicago, IL 60637, USA.
authors.forename: G E
authors.initials: GE
authors.lastname: Loss
authors.forename: H P
authors.initials: HP
authors.lastname: Grewal
authors.forename: C T
authors.initials: CT
authors.lastname: Siegel
authors.forename: D
authors.initials: D
authors.lastname: Peace
authors.forename: J
authors.initials: J
authors.lastname: Mead
authors.forename: D S
authors.initials: DS
authors.lastname: Bruce
authors.forename: D C
authors.initials: DC
authors.lastname: Cronin
authors.forename: J M
authors.initials: JM
authors.lastname: Millis
authors.forename: K A
authors.initials: KA
authors.lastname: Newell
authors.forename: E S
authors.initials: ES
authors.lastname: Woodle
mesh_terms: D000208:Acute Disease; D000328:Adult; D005260:Female; D006084:Graft Rejection / Q000473:pathology / Q000628:therapy*; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D007683:Kidney Tubular Necrosis, Acute / Q000473:pathology; D008297:Male; D010956:Plasmapheresis; D016559:Tacrolimus / Q000627:therapeutic use*; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus